Clinicopathologic application of lectin histochemistry

Bisecting GlcNAc in glioblastoma

Eiko Aoyanagi, Ken Sasai, Miho Nodagashira, Lei Wang, Hiroshi Nishihara, Hideyuki Ihara, Yoshitaka Ikeda, Shinya Tanaka

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Glycosylation is one of the most common posttranslational modifications and changes in oligosaccharide structures are associated with many human diseases including a number of cancers. Thus, discovering aberrant glycosylation patterns that serve as markers for brain tumor progression and metastasis represents an attractive strategy to improve clinicopathologic diagnosis and to provide aids to the development of novel therapies. To identify glioblastoma (GBM) cells expressing glycoproteins that contain high levels of the bisecting N-acetylglucosamine (GlcNAc) structures, lectin histochemistry was carried out using erythroagglutinating phytohemagglutinin. Although GBM frequently expressed the bisecting GlcNAc, the lectin reactivity varied among tumor regions within individual specimens. Since detailed histopathologic analysis revealed that oligosaccharides with bisecting GlcNAc structures were preferably expressed in tumor regions with low KI67 immunopositivity, immunodetection of the bisecting GlcNAc could be useful to indicate less proliferative regions in human GBM. Our study highlights the potential use of lectin histochemistry to develop new methods for diagnosis that would improve future antiglioma therapy.

Original languageEnglish
Pages (from-to)518-525
Number of pages8
JournalApplied Immunohistochemistry and Molecular Morphology
Volume18
Issue number6
DOIs
Publication statusPublished - 2010 Dec 1
Externally publishedYes

Fingerprint

Glioblastoma
Lectins
Oligosaccharides
Glycosylation
Neoplasms
Acetylglucosamine
Post Translational Protein Processing
Brain Neoplasms
Glycoproteins
Neoplasm Metastasis
Therapeutics

Keywords

  • bisecting GlcNAc
  • erythroagglutinating phytohemagglutinin
  • glioblastoma
  • N-acetylglucosaminyltransferase- III

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology
  • Medical Laboratory Technology

Cite this

Clinicopathologic application of lectin histochemistry : Bisecting GlcNAc in glioblastoma. / Aoyanagi, Eiko; Sasai, Ken; Nodagashira, Miho; Wang, Lei; Nishihara, Hiroshi; Ihara, Hideyuki; Ikeda, Yoshitaka; Tanaka, Shinya.

In: Applied Immunohistochemistry and Molecular Morphology, Vol. 18, No. 6, 01.12.2010, p. 518-525.

Research output: Contribution to journalArticle

Aoyanagi, Eiko ; Sasai, Ken ; Nodagashira, Miho ; Wang, Lei ; Nishihara, Hiroshi ; Ihara, Hideyuki ; Ikeda, Yoshitaka ; Tanaka, Shinya. / Clinicopathologic application of lectin histochemistry : Bisecting GlcNAc in glioblastoma. In: Applied Immunohistochemistry and Molecular Morphology. 2010 ; Vol. 18, No. 6. pp. 518-525.
@article{92a219c7ea504d599e060df785f10943,
title = "Clinicopathologic application of lectin histochemistry: Bisecting GlcNAc in glioblastoma",
abstract = "Glycosylation is one of the most common posttranslational modifications and changes in oligosaccharide structures are associated with many human diseases including a number of cancers. Thus, discovering aberrant glycosylation patterns that serve as markers for brain tumor progression and metastasis represents an attractive strategy to improve clinicopathologic diagnosis and to provide aids to the development of novel therapies. To identify glioblastoma (GBM) cells expressing glycoproteins that contain high levels of the bisecting N-acetylglucosamine (GlcNAc) structures, lectin histochemistry was carried out using erythroagglutinating phytohemagglutinin. Although GBM frequently expressed the bisecting GlcNAc, the lectin reactivity varied among tumor regions within individual specimens. Since detailed histopathologic analysis revealed that oligosaccharides with bisecting GlcNAc structures were preferably expressed in tumor regions with low KI67 immunopositivity, immunodetection of the bisecting GlcNAc could be useful to indicate less proliferative regions in human GBM. Our study highlights the potential use of lectin histochemistry to develop new methods for diagnosis that would improve future antiglioma therapy.",
keywords = "bisecting GlcNAc, erythroagglutinating phytohemagglutinin, glioblastoma, N-acetylglucosaminyltransferase- III",
author = "Eiko Aoyanagi and Ken Sasai and Miho Nodagashira and Lei Wang and Hiroshi Nishihara and Hideyuki Ihara and Yoshitaka Ikeda and Shinya Tanaka",
year = "2010",
month = "12",
day = "1",
doi = "10.1097/PAI.0b013e3181e3bf0d",
language = "English",
volume = "18",
pages = "518--525",
journal = "Applied Immunohistochemistry and Molecular Morphology",
issn = "1541-2016",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Clinicopathologic application of lectin histochemistry

T2 - Bisecting GlcNAc in glioblastoma

AU - Aoyanagi, Eiko

AU - Sasai, Ken

AU - Nodagashira, Miho

AU - Wang, Lei

AU - Nishihara, Hiroshi

AU - Ihara, Hideyuki

AU - Ikeda, Yoshitaka

AU - Tanaka, Shinya

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Glycosylation is one of the most common posttranslational modifications and changes in oligosaccharide structures are associated with many human diseases including a number of cancers. Thus, discovering aberrant glycosylation patterns that serve as markers for brain tumor progression and metastasis represents an attractive strategy to improve clinicopathologic diagnosis and to provide aids to the development of novel therapies. To identify glioblastoma (GBM) cells expressing glycoproteins that contain high levels of the bisecting N-acetylglucosamine (GlcNAc) structures, lectin histochemistry was carried out using erythroagglutinating phytohemagglutinin. Although GBM frequently expressed the bisecting GlcNAc, the lectin reactivity varied among tumor regions within individual specimens. Since detailed histopathologic analysis revealed that oligosaccharides with bisecting GlcNAc structures were preferably expressed in tumor regions with low KI67 immunopositivity, immunodetection of the bisecting GlcNAc could be useful to indicate less proliferative regions in human GBM. Our study highlights the potential use of lectin histochemistry to develop new methods for diagnosis that would improve future antiglioma therapy.

AB - Glycosylation is one of the most common posttranslational modifications and changes in oligosaccharide structures are associated with many human diseases including a number of cancers. Thus, discovering aberrant glycosylation patterns that serve as markers for brain tumor progression and metastasis represents an attractive strategy to improve clinicopathologic diagnosis and to provide aids to the development of novel therapies. To identify glioblastoma (GBM) cells expressing glycoproteins that contain high levels of the bisecting N-acetylglucosamine (GlcNAc) structures, lectin histochemistry was carried out using erythroagglutinating phytohemagglutinin. Although GBM frequently expressed the bisecting GlcNAc, the lectin reactivity varied among tumor regions within individual specimens. Since detailed histopathologic analysis revealed that oligosaccharides with bisecting GlcNAc structures were preferably expressed in tumor regions with low KI67 immunopositivity, immunodetection of the bisecting GlcNAc could be useful to indicate less proliferative regions in human GBM. Our study highlights the potential use of lectin histochemistry to develop new methods for diagnosis that would improve future antiglioma therapy.

KW - bisecting GlcNAc

KW - erythroagglutinating phytohemagglutinin

KW - glioblastoma

KW - N-acetylglucosaminyltransferase- III

UR - http://www.scopus.com/inward/record.url?scp=78650516281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650516281&partnerID=8YFLogxK

U2 - 10.1097/PAI.0b013e3181e3bf0d

DO - 10.1097/PAI.0b013e3181e3bf0d

M3 - Article

VL - 18

SP - 518

EP - 525

JO - Applied Immunohistochemistry and Molecular Morphology

JF - Applied Immunohistochemistry and Molecular Morphology

SN - 1541-2016

IS - 6

ER -